Joint Ebitda from 2010 to 2025

KSPI Stock   103.33  0.20  0.19%   
Joint Stock's EBITDA is increasing with slightly volatile movements from year to year. EBITDA is predicted to flatten to about 704.7 B. For the period between 2010 and 2025, Joint Stock, EBITDA quarterly trend regression had mean deviation of  211,416,631,250 and range of 822.7 B. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
1.1 T
Current Value
704.7 B
Quarterly Volatility
268.4 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Joint Stock financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Joint Stock's main balance sheet or income statement drivers, such as Reconciled Depreciation of 2.3 B, Tax Provision of 124.6 B or Depreciation And Amortization of 143.6 K, as well as many indicators such as Price To Sales Ratio of 10.03, Dividend Yield of 0.0315 or PTB Ratio of 14.83. Joint financial statements analysis is a perfect complement when working with Joint Stock Valuation or Volatility modules.
  
Check out the analysis of Joint Stock Correlation against competitors.
For more detail on how to invest in Joint Stock please use our How to Invest in Joint Stock guide.

Latest Joint Stock's Ebitda Growth Pattern

Below is the plot of the Ebitda of Joint Stock over the last few years. It is Joint Stock's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Joint Stock's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Joint Ebitda Regression Statistics

Arithmetic Mean479,703,550,000
Geometric Mean429,481,939,048
Coefficient Of Variation55.96
Mean Deviation211,416,631,250
Median325,946,000,000
Standard Deviation268,438,144,114
Sample Variance72059037215.3T
Range822.7B
R-Value0.75
Mean Square Error34141589494.2T
R-Squared0.56
Significance0.0009
Slope42,109,915,882
Total Sum of Squares1080885558229.2T

Joint Ebitda History

2025704.7 B
20241.1 T
2023998.8 B
2022704.2 B
2021533.5 B

About Joint Stock Financial Statements

Investors use fundamental indicators, such as Joint Stock's Ebitda, to determine how well the company is positioned to perform in the future. Although Joint Stock's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
EBITDA1.1 T704.7 B

Currently Active Assets on Macroaxis

When determining whether Joint Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Joint Stock's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Joint Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Joint Stock Stock:
Check out the analysis of Joint Stock Correlation against competitors.
For more detail on how to invest in Joint Stock please use our How to Invest in Joint Stock guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Consumer Finance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Joint Stock. If investors know Joint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Joint Stock listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.37
Dividend Share
2.5 K
Earnings Share
10.8
Revenue Per Share
13.3 K
Quarterly Revenue Growth
0.283
The market value of Joint Stock is measured differently than its book value, which is the value of Joint that is recorded on the company's balance sheet. Investors also form their own opinion of Joint Stock's value that differs from its market value or its book value, called intrinsic value, which is Joint Stock's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Joint Stock's market value can be influenced by many factors that don't directly affect Joint Stock's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Joint Stock's value and its price as these two are different measures arrived at by different means. Investors typically determine if Joint Stock is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Joint Stock's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.